Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis

Conclusion: Hypertension is a common cardiovascular complication in CML patients treated with second- or third-generation TKI.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research